Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe

European Journal of Cancer

Volumn 43, Issue 14, 2007, Pages 2117-2123

  Serraino, Diego ^a   Piselli, Pierluca ^b   Busnach, Ghil ^c   Burra, Patrizia ^d   Citterio, Franco ^e   Arbustini, Eloisa ^f   Baccarani, Umberto ^g   De Juli, Emanuela ^c   Pozzetto, Ubaldo ^h   Bellelli, Stefania ^a   Polesel, Jerry ^a   Pradier, Christian ⁱ   Maso, Luigino Dal ^a   Angeletti, Claudio ^b   Carrieri, Maria Patrizia ^j   Rezza, Giovanni ^k   Franceschi, Silvia ^l  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^g Azienda Ospedaliera   (Italy)

^h CNR   (Italy)

ⁱ CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^j INSERM   (France)

^k ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^l INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

Acquired immunodeficiency; Cancer; France; HIV infection; Italy; Organ transplantation; SIR

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER; CANCER RISK; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EUROPE; FEMALE; FOLLOW UP; FRANCE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; ITALY; KAPOSI SARCOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ADULT; AGED; COHORT STUDIES; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSION; ITALY; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS; TRANSPLANTATION;

EID: 34548523833     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.07.015     Document Type: Article

References (31)

1. Doll R., and Kinlen L. Immunosurveillance and cancer: epidemiological evidence. Br Med J 4 (1970) 420-422
2. International Collaboration on HIV and Cancer. The impact of highly active anti-retroviral therapy on the incidence of cancer in people infected with the human immunodeficiency virus. Collaborative reanalysis of individual data on 47,936 HIV-infected people from 23 cohort studies in 12 developed countries. J Natl Cancer Inst 2000; 92: 1823-30.
3. Kinlen L.J. Infections and immune factors in cancer: the role of epidemiology. Oncogene 23 (2004) 6341-6348
4. Adami J., Gabel H., Lindelof B., et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 89 (2003) 1221-1227
5. Dal Maso L., Franceschi S., Polesel J., et al. Risk of cancer in persons with AIDS in Italy, 1985-98. Br J Cancer 89 (2003) 94-100
6. Clifford G.M., Polesel J., Rickenbach M., et al. Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97 (2005) 425-432
7. Serraino D., Boschini A., Carrieri M.P., et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 14 (2000) 553-559
8. Franceschi S., Dal Maso L., Pezzotti P., et al. Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998. J Acquir Immune Defic Syndr 34 (2003) 84-90
9. Mbulaiteye S.M., Biggar R.J., Goedert J.J., and Engles E.A. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 32 (2003) 527-533
10. Dantal J., Houmant M., Cantarovich D., et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporine regimens. Lancet 351 (1998) 623-628
11. Guba M., von Breitenbuch P., Steinbauer M., et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8 (2002) 128-135
12. Stallone G., Schen A., Infante B., et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 352 (2005) 1317-1323
13. Serraino D., Piselli P., Angeletti C., et al. Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. B J Cancer 92 (2005) 572-575
14. Pedotti P., Cardillo M., Rossini G., et al. Incidence of cancer after kidney transplant: results from the North Italy transplant program. Transplantation 76 (2003) 1448-1451
15. Herrero J.L., Lorenzo M., Quiroga J., et al. De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transplantation 11 (2005) 89-97
16. Serraino D., Angeletti C., Carrieri P., et al. Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France. Transplantation 80 (2005) 1699-1704
17. World Health Organization. International classification of diseases and related problems. 10th rev. Geneva: World Health Organization; 1992.
18. Parkin DM, Whelan SL, Ferlay J, et al, editors. Cancer incidence in five continents, vol. VII. IARC Scientific Publications No. 143. Lyon: IARC Press; 1997.
19. Breslow NE, Day NE. Statistical methods in cancer esearch, vol. 2. The design and analysis of cohort studies. IARC Scientific Publications No. 82. Lyon :IARC Press; 1987.
20. Kaplan E.L., and Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
21. Feng S, Buell JF, Chari RS, Di Maio JM, Manto DW. Tumors and transplantation: the 2003 third annual ASTS state-of-the-art winter symposium. Am J Transplant 2003; 3: 1481-87.
22. Hoshida Y., Tsukuma H., Yasunaga Y., et al. Cancer risk after renal transplantation in Japan. Int J Cancer 71 (1997) 517-520
23. Vajdic C.M., McDonald S.P., McCredie M.R.E., et al. Cancer incidence before and after kidney transplantation. JAMA 296 (2006) 2823-2831
24. Lindelof B., Sigurgeirsson B., Gabel H., and Stern R.S. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 143 (2000) 513-519
25. Kasike B.L., Snyder J.J., Gilbertosn D.T., and Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 4 (2004) 905-913
26. Petrosillo N., Puro V., and Ippolito. Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients. The Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-Borne Infections in Dialysis. Nephron 64 (1993) 636-639
27. Engels E.A., Brock M.V., Chen J., Hooker C.M., Gillison M., and Moore R.D. Elevated Incidence of Lung Cancer Among HIV-Infected Individuals. J Clin Oncol 24 (2006) 1383-1388
28. Birkeland S.A., Storm H.H., Lamm L.U., et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 60 (1995) 183-189
29. Kyllönen L., Salmela K., and Pukkala E. Cancer incidence in a kidney-transplanted population. Transpl Int 13 Suppl. 1 (2000) S394-S398
30. Herida M., Mary-Krause M., Kaphan R., et al. Incidence of Non-AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus-Infected Patients. J Clin Oncol 21 (2003) 3447-3453
31. Engels E.A., Pfeiffer R.M., Goedert J.J., et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 20 (2006) 1645-1654